Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Flühmann

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2020
Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practiceNiusha Nikravesh, Gerrit Borchard, Heinrich Hofmann, et al.
ESC Heart Failure|January 30, 2019
Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patientsAlejandro Martin-Malo, Gerrit Borchard, Beat Flühmann, et al.
Biosensors|October 27, 2022
Probing Subcellular Iron Availability with Genetically Encoded Nitric Oxide BiosensorsGulsah Sevimli, Amy E Alston, Felix Funk, et al.
FEBS Letters|November 19, 2002
The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptideDaniela Koller, Walter Born, Kerstin Leuthäuser, et al.
Clinical Pharmacokinetics|August 15, 2025
Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a RoadmapAmy Barton Alston, Zhoumeng Lin, Heather Herd Gustafson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 9, 2023
Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structureLeonard Krupnik, Prachi Joshi, Andreas Kappler, et al.
Annals of the New York Academy of Sciences|July 23, 2021
A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathwaysKevin Klein, Gerrit Borchard, Vinod P Shah, et al.
International Journal of Molecular Sciences|March 10, 2022
Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron-Carbohydrate Nanoparticles from SerumTasneem Arsiwala, Anne-Cathrine S Vogt, Amy E Barton, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 1, 2023
Uncovering the dynamics of cellular responses induced by iron-carbohydrate complexes in human macrophages using quantitative proteomics and phosphoproteomicsJonas Bossart, Alexandra Rippl, Amy E Barton Alston, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 2021
Tackling the challenges of nanomedicines: are we ready?John B Hertig, Vinod P Shah, Beat Flühmann, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2020
Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practiceNiusha Nikravesh, Gerrit Borchard, Heinrich Hofmann, et al.
ESC Heart Failure|January 30, 2019
Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patientsAlejandro Martin-Malo, Gerrit Borchard, Beat Flühmann, et al.
Biosensors|October 27, 2022
Probing Subcellular Iron Availability with Genetically Encoded Nitric Oxide BiosensorsGulsah Sevimli, Amy E Alston, Felix Funk, et al.
FEBS Letters|November 19, 2002
The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptideDaniela Koller, Walter Born, Kerstin Leuthäuser, et al.
Clinical Pharmacokinetics|August 15, 2025
Challenging Traditional ADME Assumptions for Physiologically Based Pharmacokinetic Models for Intravenous Administration of Iron-Carbohydrate Nanomedicines: Potential Utility of Gold Nanoparticle Models as a RoadmapAmy Barton Alston, Zhoumeng Lin, Heather Herd Gustafson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 9, 2023
Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structureLeonard Krupnik, Prachi Joshi, Andreas Kappler, et al.
Annals of the New York Academy of Sciences|July 23, 2021
A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathwaysKevin Klein, Gerrit Borchard, Vinod P Shah, et al.
International Journal of Molecular Sciences|March 10, 2022
Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron-Carbohydrate Nanoparticles from SerumTasneem Arsiwala, Anne-Cathrine S Vogt, Amy E Barton, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 1, 2023
Uncovering the dynamics of cellular responses induced by iron-carbohydrate complexes in human macrophages using quantitative proteomics and phosphoproteomicsJonas Bossart, Alexandra Rippl, Amy E Barton Alston, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 2021
Tackling the challenges of nanomedicines: are we ready?John B Hertig, Vinod P Shah, Beat Flühmann, et al.
Pageof 4